MSD Korea Ltd.
Korean subsidiary of a global healthcare company. Local activities include vaccine research and platform development, oncology clinical development, design and execution of regulated clinical studies, pharmacovigilance and safety reporting, regulatory filings and labeling management, medical information and education for healthcare professionals, and local supply, distribution and commercialization of prescription medicines and vaccines. The company maintains documented data-privacy and records-retention policies and operates with contractual arrangements for third-party vendors and cloud/SaaS providers across clinical, laboratory and business functions.
Industries
N/A
Nr. of Employees
small (1-50)
MSD Korea Ltd.
Products
Portfolio of prescription medicines and vaccines
Local supply and commercialization of a portfolio of prescription medicines and vaccines for the Korean market.
Introduction of regulatory-authorized product formulations
Local introduction of newly authorized medicines and vaccine formulations following regulatory approval.
Portfolio of prescription medicines and vaccines
Local supply and commercialization of a portfolio of prescription medicines and vaccines for the Korean market.
Introduction of regulatory-authorized product formulations
Local introduction of newly authorized medicines and vaccine formulations following regulatory approval.
Services
Deliver clinical and product information to healthcare professionals and organize educational programs and disease-awareness activities.
Design and operate regulated clinical studies and engage with investigators and sites, coordinating outsourced vendors for trial services in Korea.
Manage regulatory filings, approvals and product labeling updates and coordinate communications with Korean regulatory authorities.
Governance of personal and clinical data handling, consent and data-subject rights, secure retention and disposal practices, and contractual oversight of outsourced clinical, laboratory and cloud/SaaS providers; includes documented cross-border transfer practices and mechanisms for individuals to withdraw consent to transfers where applicable.
Deliver clinical and product information to healthcare professionals and organize educational programs and disease-awareness activities.
Design and operate regulated clinical studies and engage with investigators and sites, coordinating outsourced vendors for trial services in Korea.
Manage regulatory filings, approvals and product labeling updates and coordinate communications with Korean regulatory authorities.
Governance of personal and clinical data handling, consent and data-subject rights, secure retention and disposal practices, and contractual oversight of outsourced clinical, laboratory and cloud/SaaS providers; includes documented cross-border transfer practices and mechanisms for individuals to withdraw consent to transfers where applicable.
Expertise Areas
- Vaccine research and platform development
- Oncology clinical development and trial operations
- Pharmacovigilance and safety reporting
- Regulatory submissions and labeling management
Key Technologies
- Electronic data capture (EDC) and eCRF systems
- Central laboratory testing and sample logistics
- Clinical imaging core‑lab integration
- Central ECG collection systems
News & Updates
Reported supply of about 50 prescription medicines and vaccines in Korea (2024).
Reported domestic R&D investment of 720억원 (KRW) in 2024.
Reported headcount of 505 employees in Korea (2025).
Published an updated privacy policy specifying secure deletion methods, third-party processing arrangements, cross-border transfer practices and retention schedules.
Reported supply of about 50 prescription medicines and vaccines in Korea (2024).
Reported domestic R&D investment of 720억원 (KRW) in 2024.
Reported headcount of 505 employees in Korea (2025).
Published an updated privacy policy specifying secure deletion methods, third-party processing arrangements, cross-border transfer practices and retention schedules.